miércoles, 24 de enero de 2024

What are the capabilities of a commercially available p-tau217 immunoassay to identify Alzheimer disease pathophysiology?

https://www.news-medical.net/news/20240124/What-are-the-capabilities-of-a-commercially-available-p-tau217-immunoassay-to-identify-Alzheimer-disease-pathophysiology.aspx

No hay comentarios:

Publicar un comentario